cyc 202 has been researched along with pyrazole in 1 studies
Studies (cyc 202) | Trials (cyc 202) | Recent Studies (post-2010) (cyc 202) | Studies (pyrazole) | Trials (pyrazole) | Recent Studies (post-2010) (pyrazole) |
---|---|---|---|---|---|
979 | 7 | 393 | 1,152 | 0 | 596 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bai, XG; He, HW; Li, XM; Shao, RG; Wang, JX; Wang, YC; Yu, DK; Zhang, H | 1 |
1 other study(ies) available for cyc 202 and pyrazole
Article | Year |
---|---|
Design, synthesis and anticancer activity of 1-acyl-3-amino-1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole derivatives.
Topics: Antineoplastic Agents; Binding Sites; Cell Line, Tumor; Cyclin-Dependent Kinase 5; Drug Design; Drug Screening Assays, Antitumor; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; HCT116 Cells; Humans; Molecular Docking Simulation; Protein Kinases; Protein Structure, Tertiary; Purines; Pyrazoles; Pyrroles; Roscovitine; Structure-Activity Relationship | 2012 |